InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Browse the complete record of transactions filed by WITTE OWEN N., Director. Director active across 2 companies, notably Allogene Therapeutics, Inc.. Aggregated, 8 disclosures have been logged. Total volume traded: €940k. The latest transaction was filed on 22 June 2022 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations8 total
€111,32010,000 shares@ €11.1320.016% mcap21.2% of flow
Common Stock
SEC:0001214659-22-008272:0·
022,089 shares0
Common Stock
SEC:0001214659-22-008169:0·
€107,9835,000 shares@ €21.59660.035% mcap26.1% of flow
Common Stock
SEC:0001214659-21-009372·
€107,9835,000 shares@ €21.59660.016% mcap20.5% of flow
Common Stock
SEC:0001214659-21-009372:0·
€101,4855,000 shares@ €20.2970.033% mcap24.5% of flow
Common Stock
SEC:0001214659-21-008900·
€101,4855,000 shares@ €20.2970.015% mcap19.3% of flow
Common Stock
SEC:0001214659-21-008900:0·
€204,9949,969 shares@ €20.56310.030% mcap39.0% of flow
Common Stock
SEC:0001214659-21-006504:0·
€204,9949,969 shares@ €20.56310.067% mcap49.5% of flow
Common Stock
SEC:0001214659-21-006504·
8 of 8 declarations
About WITTE OWEN N.
Owen N. Witte is a Director at Allogene Therapeutics, Inc., a company specializing in gene therapies. In his role, he contributes to the strategy and governance of the firm, ensuring that Allogene meets industry standards and shareholder expectations.
